Secondly, and more importantly, it will also open the way for future investigations to understand the mechanisms underlying the negative impact of KLK4 expression/activity on advanced PCa tumor growth and metastasis formation in order to identify novel possible targets. The gene discussed is KLK4; the disease is posterior cortical atrophy.